Advances in Ophthalmology

Advanced and comprehensive eye care from New York’s #1 Hospital.

The Edward Harkness Eye Institute at NewYork-Presbyterian/Columbia University Irving Medical Center and the Department of Ophthalmology at NewYork-Presbyterian/Weill Cornell Medical Center offer patients the most advanced, comprehensive, and effective eye care. Our dedicated physicians use the latest advances in diagnostic technology and therapy to prevent, detect, and treat every conceivable disorder of the eye. This approach to ophthalmology is combined with a commitment to a wide range of clinical specializations.

image of doctors performing eye surgery in an OR

Advancing the Boundaries of Innovation in Ophthalmic Surgery

Harnessing decades of clinical experience and the latest developments in cutting-edge surgical technology, the Ophthalmology program at NewYork-Presbyterian/Weill Cornell Medical Center is advancing the boundaries of innovation in the treatment of complex eye disorders.

image of monitor and program used during eye surgery

Spotlight on Ophthalmic Surgery Innovations

Innovations include: K-Pro for Corneal Repair, Stereoscopic 3D “Heads Up” Digital Visualization System, Amniotic Membrane Application for Severe Ocular Surface Disease, OculoPlastics Expertise for Transorbital Neurosurgery, & PROSE for Complex Corneal Disease.

vector illustration of dna

Realizing the Vision of Precision Ophthalmology™ at Columbia

After decades of pioneering research and clinical achievements, we are making groundbreaking advances in Precision Ophthalmology. Defined as customized genetic, diagnostic, and translational clinical care, Precision Ophthalmology uses a patients’ genetic profile to tailor treatment designed for them.

image of doctors and nurses in an operating room looking at a monitor during eye surgery

Strength in Collaboration: Columbia and Weill Cornell Ophthalmology at NewYork-Presbyterian Hospital

Columbia and Weill Cornell ophthalmologists propelled the transformative growth of the Ophthalmology services at NewYork-Presbyterian by providing advanced treatment for eye diseases and unmatched research and educational opportunities for the leaders of tomorrow.

image of Dr. Simon John

Glaucoma and Genetics Come Into Focus

Dr. John shares his groundbreaking research on the molecular basis of glaucoma, uniting engineering and technology with molecular, genetic, and physiologic methods to identify the genes and molecular mechanisms underlying this neurodegenerative disease.

image of Dr. Ashley Brissette and Dr. Kimberly C. Sippel

Elevating Precision and Safety in Cataract Surgery

With the addition of femtosecond laser for cataract extraction and two innovative optical systems for measuring the refractive power of the eye during surgery itself, NewYork-Presbyterian/Weill Cornell Medical Center is able to offer patients visual results that have been documented to exceed national averages.

image of operating room

Fulfilling a Vision for Superior Ophthalmic Care

The partnership between NewYork-Presbyterian and Weill Cornell Medicine has propelled the growth of the Department of Ophthalmology at NewYork-Presbyterian/Weill Cornell Medical Center, which is transforming ophthalmic surgery with our focus on advanced technology and extraordinary facilities.

image of Precision Ophthalmology 2020 Applied Genetics pdf cover

Precision Ophthalmology 2020

A leading international center for the management of sight-threatening disorders, the Department of Ophthalmology at Columbia University Irving Medical Center is continuing the tradition of innovation with Precision Ophthalmology 2020.

image of Dr. Christopher S. Sales

DMEK: Corneal Transplant Surgery Comes of Age

DSAEK revolutionized corneal transplant surgery by eliminating problems associated with full-thickness, sutured grafts. Dr. Christopher S. Sales at NewYork-Presbyterian/Weill Cornell Medical Center is helping to preserve normal corneal anatomy with DMEK.

image of Megan Soucy and Dr. Jeffrey M. Liebmann

Glaucoma: Accelerating Genetic Discoveries for Clinical Applications

With the support of a major award from The Brown Foundation, Dr. Jeffrey M. Liebmann and his team have launched the Brown Glaucoma Genetics Initiative, a continuum of investigative and therapeutic projects with the aim of developing treatments for specific subtypes of the disease.

Newsletters for Medical Professionals

2020 Issue 1

2019 Issue 1

2018 Issue 1

2017 Issue 1

2016 Issue 3

Spring 2016

Fall/Winter 2015

Summer 2015

November/December 2014